Treatment Planning (Protons vs. Photons)

Size: px
Start display at page:

Download "Treatment Planning (Protons vs. Photons)"

Transcription

1 Treatment Planning Treatment Planning (Protons vs. Photons) Acquisition of imaging data Delineation of regions of interest Selection of beam directions Dose calculation Optimization of the plan Hounsfield Units (HU)? HU Photon Planning System HU versus electron density Proton Planning System HU versus rel. stopping power 7/28/ /28/ Treatment Planning (Protons vs. Photons) Proton beams (fields) have an end of range (i.e. pointing to critical structures is an option) Treatment Planning (Protons vs. Photons) Isodose levels The PTV concept is not applicable in proton therapy Planned to the PTV Dose versus time 7/28/ Martijn Engelsman, MGH 7/28/

2 Treatment Planning Dose shaping for passive scattered protons Passive scattered proton beams Scanned proton beams Intensity modulated proton beams Comparative treatment plans Beam High-Density Structure Target Volume Critical Structure Double scattering system Aperture Body Surface 7/28/ Hanne Kooy, MGH 7/28/ SOBP Modulation Aperture and Range Compensator High-Density Structure Target Volume + = Beam Critical Structure Aperture Body Surface Prescription: Range Modulation Compensator Aperture 7/28/2008 Hanne Kooy, MGH 7 To be designed by the planning system! 7/28/2008 Hanne Kooy, MGH 8 2

3 Dosimetry and QA for SOBP proton fields Range and Modulation Width for each field Dose [%] Dose [%] Dose [%] 40 Beam range: cm 20 Modulation width: 6.78 cm Depth [mm] Depth [mm] 7/28/ Beam range: cm 20 Modulation width: 8.65 cm Depth [mm] Beam range: 12.0 cm Modulation width: 4.0 cm Volume for absolute dosimetry Output Factor D cal cgy MU 7/28/ i ic 2. Absolute dosimetry for each field A SIMPLE EXAMPLE: Para-spinal case using 3 fields Field Patching 10 Gy 15 Gy 20 Gy 25 Gy 30 Gy 35 Gy 40 Gy 45 Gy 46 Gy brainstem CTV B PTV Critical Structure C A Useful if target is close to critical structures Not necessarily homogeneous dose to the target for each beam (IM!) Range and penumbra uncertainties need to be considered 7/28/ /28/

4 A COMPLICATED EXAMPLE: Nasopharynx case using 14 fields (plus additional photon fields to the lower neck) CTV-2 25 Gy 30 Gy 35 Gy 40 Gy 45 Gy 50 Gy 55 Gy 60 Gy 67 Gy 7/28/ /28/ Marc Bussiere, MGH CTV-2 Parotid Brainstem CTV-1 Treating moving targets with protons Spinal Cord GTV 76 Gy CTV Gy CTV2 60 Gy 7/28/ Nodes 54 Gy 7/28/

5 Effect of respiration on dose FH Burr Proton Therapy Center (2001-) Patient Population Brain 32% Rescanning Spine 23% Beam Gating Real time tumor tracking with markers Prostate 12% Skull Base 12% Head & Neck 7% Trunk/Extremity Sarcomas R L 6% posterior view Gastrointestinal 6% posterior cut Lung 1% In general, 1-3 fields / day / patient Currently ~ 45 patients / day 7/28/2008 Eike Rietzel 17 Shinishiro Mori, MGH 7/28/ Thomas DeLaney, MGH Treatment Planning Beam Scanning Passive scattered proton beams Scanned proton beams Intensity modulated proton beams Comparative treatment plans Intensity Modulated Beam Pair of Quads Scanning Magnets Fast Slow Vacuum Chamber Beam monitor 0.8 m 0.6 m Y Z X 7/28/ No double scattering system No modulator wheels No aperture No range compensator 7/28/

6 Beam Scanning 1 1. Evenly spaced/weighted spots to achieve uniform field 2. 1mm spot error due to delivery error or patient motion. Typical Spot Beam in Water 3. Optimum spacing/weighting to achieve sharper penumbra 2 3 Eros Pedroni, PSI 7/28/ Pedroni Eros Pedroni, PSI 7/28/ Dosimetry and QA of pencil beams Energy/Range large number of energies required energy spacing must provide dose uniformity over all depths Spot size and shape spot size/shape may depend on energy spot position accuracy Measurements require methods for rapid collection large amounts of data Real-time beam information Ionization Chamber Array Water column with 26 small ionization chambers of 0.1 cm 3 Dose box PTCOG 46 Educational Workshop Pedroni, PSI, Switzerland Pedroni, PSI, Switzerland Orthogonal IC array measurements performed at different water depthsusing acomputercontrolledwatercolumnand compared with calculations. Beam s-eye-view of dose in water U axis profile Mirror M D Anderson Cancer Center CCD Scintillating Plate, Mirror and Camera CCD Camera used for pencil beam scanning QA. Scintillating Plate Beam Spot Pattern Test Uniform Field Scanning Test Scintillating screen viewed with a ideal for non homogeneous dose distributions CCD through a 45 mirror WER W= 6.65 cm 6.65 CM WE W= 7.82 cm R 7.82 CM 7/28/ Alfred Smith, MDACC T axis profile Measurement vs. Calculation 7/28/ PTCOG 46 Educational Workshop Pedroni, PSI, Switzerland Alfred Smith, MDACC 6

7 Treatment Planning Passive scattered proton beams Scanned proton beams Intensity modulated proton beams Comparative treatment plans IMPT Treatment Planning Bragg peaks of pencil beams are distributed throughout the planning volume Pencil beam weights are optimized for several beam directions simultaneously (inverse planning) 7/28/ Alex Trofimov, MGH 7/28/ Intensity-Modulated Proton Therapy IMPT Treatment Planning Passive scattered proton beams Scanned proton beams Intensity modulated proton beams Comparative treatment plans 7/28/ Alex Trofimov, MGH 7/28/

8 Example (passive scattered protons vs. photons) Protons Medulloblastoma Photons Medulloblastoma 7/28/ /28/2008 Copyright MGH/NPTC Example (protons vs. IM photons) Prostate carcinoma: (GTV + 5mm) to 79.2 Gy (CTV + 5mm) to 50.4 Gy (a) IMRT Prostate (b) Pass. Sc. Protons (c) Dose [Gy] IMPT Dose [CGE] Dose [CGE] 7/28/ Alex Trofimov, MGH 7/28/

9 Example (protons / IM protons / IM photons) Nasopharynx (case shown earlier) 7/28/ /28/ Alex Trofimov, MGH A Passive scattered protons (14 proton fields, 4 photon fields) proton fields CTV to 59.4 GyE (33 x 1.8 Gy) GTV to 70.2 GyE (+ 6 x 1.8 Gy) Photon fields lower neck, nodes to 60 Gy B Photon IMRT plan (7 coplanar photon beams) G N N G 7/28/ /28/ Alex Trofimov, MGH Alex Trofimov, MGH 9

10 C IMPT plan (4 coplanar proton beams) DVH for target structures Comparable target coverage 7/28/ /28/ Alex Trofimov, MGH Alex Trofimov, MGH DVH for some critical structures Summary 7/28/ Proton planning offers more options in terms of beam directions and field shaping than photon planning IMRT and 3D protons can be comparable in terms of dose conformality Protons are able to reduce the dose to most critical structures compared to photons Proton therapy is able to reduce the integral dose compared to photons by up to a factor of 3 IMPT is the method of choice Alex Trofimov, MGH 7/28/

11 Some remarks on biology Integral dose (protons vs. photons) Neutrons in proton therapy The proton RBE 7/28/ Advantage protons!!! Dis-advantage protons??? 7/28/ Neutron dose as a function of lateral distance Field 1 Zacharatou Jarlskog and Paganetti: 7/28/2008 Zacharatou Jarlskog and Paganetti: Int. J. Radiat. Biol. Phys. 2008, in press 43 7/28/2008 Field 2 Field 3 Int. J. Radiat. Biol. Phys. 2008, in press 44 11

12 Neutron radiation weighting factor Neutron RBE as a function of endpoint Estimates of RBE M for neutron carcinogenesis in mice From: Annals of the ICRP; ICRP Publication 92; Relative Biological Effectiveness (RBE), Quality Factor (Q), and Radiation Weighting Factor (w R ) 7/28/ NCRP Report No. 104, The Relative Biological Effectiveness of Radiations of Different Quality 7/28/ RBE in proton therapy: RBE values in vivo (center of SOBP; relative to 60 Co) 2.5 Clinical (generic) RBE = 1.1* RBE * Based on experiments at the Harvard cyclotron done in the 70 s 7/28/ Dose per fraction [Gy] Mice data: Lung tolerance,crypt regeneration,acute skin reactions,fibrosarcoma NFSa Paganetti et al.: Int. J. Radiat. Oncol. Biol. Phys. 2002; 53, /28/

13 RBE as a function of LET be careful when using the end of range next to a critical structure RBE as a function of dose dose dependency seems to be small RBE as a function of biological endpoint variation seems to be small Note: RBE for cell kill can be different than for mutation/carcinogenesis 7/28/ RBE as a function of particle energy / LET Radiation is more effective when energy depositions are more concentrated in space p+ 7/28/ M. Krämer, W. K. Weyrather, M. Scholz: Techn. Cancer Res. Treatm. 2, , 2003 Thanks to Hanne Kooy Alex Trofimov George Chen Martijn Engelsman Judy Adams for providing some slides and figures 7/28/

Specifics of treatment planning for active scanning and IMPT

Specifics of treatment planning for active scanning and IMPT Specifics of treatment planning for active scanning and IMPT SFUD IMPT Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland Treatment planning for scanning 1. Single Field,

More information

Treatment Planning for Skull Base Tumors PTCOG 52, June 2013

Treatment Planning for Skull Base Tumors PTCOG 52, June 2013 Treatment Planning for Skull Base Tumors PTCOG 52, June 2013 Judy Adams CMD Hanne Kooy Ph.D, Norbert Liebsch MD Department of Radiation Oncology Massachusetts General Hospital Chordomas and Chondrosarcomas

More information

State-of-the-art proton therapy: The physicist s perspective

State-of-the-art proton therapy: The physicist s perspective State-of-the-art proton therapy: Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland Overview of presentation 1. State-of-the-art proton delivery 2. Current challenges 3. New

More information

Discuss the general planning concepts used in proton planning. Review the unique handling of CTV / ITV / PTV when treating with protons

Discuss the general planning concepts used in proton planning. Review the unique handling of CTV / ITV / PTV when treating with protons Mark Pankuch, PhD Discuss the general planning concepts used in proton planning Review the unique handling of CTV / ITV / PTV when treating with protons Pencil Beam distributions and PBS optimization Cover

More information

Range Uncertainties in Proton Therapy

Range Uncertainties in Proton Therapy Range Uncertainties in Proton Therapy Harald Paganetti PhD Professor of Radiation Oncology, Harvard Medical School Director of Physics Research, Massachusetts General Hospital, Department of Radiation

More information

Clinical considerations of RBE in proton therapy

Clinical considerations of RBE in proton therapy Clinical considerations of RBE in proton therapy H. Paganetti PhD Professor, Harvard Medical School Director of Physics Research, Massachusetts General Hospital, Radiation Oncology Why do we need the RBE

More information

8/3/2016. Clinical Significance of RBE Variations in Proton Therapy. Why RBE (relative biological effectiveness)?

8/3/2016. Clinical Significance of RBE Variations in Proton Therapy. Why RBE (relative biological effectiveness)? 8//06 Clinical Significance of Variations in Proton Therapy H. Paganetti PhD Professor, Harvard Medical School Director of Physics Research, Massachusetts General Hospital, Radiation Oncology Introduction

More information

Predicting the risk of developing a radiationinduced second cancer when treating a primary cancer with radiation

Predicting the risk of developing a radiationinduced second cancer when treating a primary cancer with radiation Remaining physics challenges in proton therapy Predicting the risk of developing a radiationinduced second cancer when treating a primary cancer with radiation H. Paganetti PhD Professor and Director of

More information

Status of H 1 and C 12

Status of H 1 and C 12 Status of H 1 and C 12 Herman Suit No Conflict of Interest 1 Goal of a New Treatment Modality Tumor Control Probability or No in Complication Rate 2 Truism No Advantage to: any Patient for any Radiation

More information

Topics covered 7/21/2014. Radiation Dosimetry for Proton Therapy

Topics covered 7/21/2014. Radiation Dosimetry for Proton Therapy Radiation Dosimetry for Proton Therapy Narayan Sahoo Department of Radiation Physics University of Texas MD Anderson Cancer Center Proton Therapy Center Houston, USA Topics covered Detectors used for to

More information

Proton Stereotactic Radiotherapy: Clinical Overview. Brian Winey, Ph.D. Physicist, MGH Assistant Professor, HMS

Proton Stereotactic Radiotherapy: Clinical Overview. Brian Winey, Ph.D. Physicist, MGH Assistant Professor, HMS Proton Stereotactic Radiotherapy: Clinical Overview Brian Winey, Ph.D. Physicist, MGH Assistant Professor, HMS Acknowledgements Radiation Oncologists and Physicists at various institutions (MGH, MDACC,

More information

Future Directions in Prostate Cancer: The Case for Protons. John J. Coen, MD Helen & Harry Gray Cancer Center

Future Directions in Prostate Cancer: The Case for Protons. John J. Coen, MD Helen & Harry Gray Cancer Center Future Directions in Prostate Cancer: The Case for Protons John J. Coen, MD Helen & Harry Gray Cancer Center November 14, 2012 Protons and prostate cancer Early proton experience at the MGH The case for

More information

Hampton University Proton Therapy Institute

Hampton University Proton Therapy Institute Hampton University Proton Therapy Institute Brief introduction to proton therapy technology, its advances and Hampton University Proton Therapy Institute Vahagn Nazaryan, Ph.D. Executive Director, HUPTI

More information

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning Supervisors Prof. V. Patera PhD R. Van Roermund Candidate Annalisa Patriarca

More information

PRESCRIBING RECORDING AND REPORTING PROTON BEAM THERAPY ICRU 78. RAJESH THIYAGARAJAN Senior Medical Physicist & RSO Medanta The Medicity

PRESCRIBING RECORDING AND REPORTING PROTON BEAM THERAPY ICRU 78. RAJESH THIYAGARAJAN Senior Medical Physicist & RSO Medanta The Medicity PRESCRIBING RECORDING AND REPORTING PROTON BEAM THERAPY ICRU 78 RAJESH THIYAGARAJAN Senior Medical Physicist & RSO Medanta The Medicity HISTORY OF PROTON THERAPY Robert Wilson proposed the use of proton

More information

IMPT with Carbon Ions

IMPT with Carbon Ions IMPT with Carbon Ions PTCOG 48, Heidelberg, 28.09.-03.10.2009 Malte Ellerbrock Medical Physics Expert Heidelberg Ion-Beam Therapy Center HIT Betriebs GmbH am Universitätsklinikum Heidelberg http://www.hit-centrum.de

More information

Advances in external beam radiotherapy

Advances in external beam radiotherapy International Conference on Modern Radiotherapy: Advances and Challenges in Radiation Protection of Patients Advances in external beam radiotherapy New techniques, new benefits and new risks Michael Brada

More information

Specification of Tumor Dose. Prescription dose. Purpose

Specification of Tumor Dose. Prescription dose. Purpose Specification of Tumor Dose George Starkschall, Ph.D. Department of Radiation Physics U.T. M.D. Anderson Cancer Center Prescription dose What do we mean by a dose prescription of 63 Gy? Isocenter dose

More information

Proton and heavy ion radiotherapy: Effect of LET

Proton and heavy ion radiotherapy: Effect of LET Proton and heavy ion radiotherapy: Effect of LET As a low LET particle traverses a DNA molecule, ionizations are far apart and double strand breaks are rare With high LET particles, ionizations are closer

More information

Considerations when treating lung cancer with passive scatter or active scanning proton therapy

Considerations when treating lung cancer with passive scatter or active scanning proton therapy Mini-Review Considerations when treating lung cancer with passive scatter or active scanning proton therapy Sara St. James, Clemens Grassberger, Hsiao-Ming Lu Department of Radiation Oncology, Massachusetts

More information

8/1/2016. Motion Management for Proton Lung SBRT. Outline. Protons and motion. Protons and Motion. Proton lung SBRT Future directions

8/1/2016. Motion Management for Proton Lung SBRT. Outline. Protons and motion. Protons and Motion. Proton lung SBRT Future directions Motion Management for Proton Lung SBRT AAPM 2016 Outline Protons and Motion Dosimetric effects Remedies and mitigation techniques Proton lung SBRT Future directions Protons and motion Dosimetric perturbation

More information

doi: /j.ijrobp

doi: /j.ijrobp doi:10.1016/j.ijrobp.2010.08.006 Int. J. Radiation Oncology Biol. Phys., Vol. 80, No. 3, pp. 928 937, 2011 Copyright Ó 2011 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/$ - see front

More information

Proton Therapy Dosimetry & Clinical Implementation. Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine

Proton Therapy Dosimetry & Clinical Implementation. Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine Proton Therapy Dosimetry & Clinical Implementation Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine Outline» Proton Therapy Basics» Why Proton Therapy? (Dosimetric Superiority)»

More information

The Rise, Fall, and Rise Again of Proton Therapy or Never count out a well-financed therapy

The Rise, Fall, and Rise Again of Proton Therapy or Never count out a well-financed therapy The Rise, Fall, and Rise Again of Proton Therapy or Never count out a well-financed therapy Anthony Zietman MD Shipley Professor of Radiation Oncology Massachusetts General Hospital Harvard Medical School

More information

Dosimetry and QA of proton and heavier ion beams

Dosimetry and QA of proton and heavier ion beams Dosimetry and QA of proton and heavier ion beams Stanislav Vatnitskiy EBG MedAustron GmbH Wiener Neustadt, Austria Content Introduction Reference dosimetry Methods, detectors, protocols Dosimetry in non-reference

More information

Clinical Report for Wanjie Proton Therapy Center. Li Jiamin, MD Wanjie Proton Therapy Center

Clinical Report for Wanjie Proton Therapy Center. Li Jiamin, MD Wanjie Proton Therapy Center Clinical Report for Wanjie Proton Therapy Center Li Jiamin, MD Wanjie Proton Therapy Center General Information Wanjie Proton Therapy Center was founded in June 2001 The first patient was treated in Dec.

More information

Proton Therapy for Prostate Cancer. Andrew K. Lee, MD, MPH Director Proton Therapy Center

Proton Therapy for Prostate Cancer. Andrew K. Lee, MD, MPH Director Proton Therapy Center Proton Therapy for Prostate Cancer Andrew K. Lee, MD, MPH Director Proton Therapy Center Disclosures No relevant financial disclosures This presentation will not discuss off-label or investigational treatments

More information

To Reduce Hot Dose Spots in Craniospinal Irradiation: An IMRT Approach with Matching Beam Divergence

To Reduce Hot Dose Spots in Craniospinal Irradiation: An IMRT Approach with Matching Beam Divergence SCIENCE & TECHNOLOGY To Reduce Hot Dose Spots in Craniospinal Irradiation: An IMRT Approach with Matching Beam Divergence Alburuj R. Rahman*, Jian Z. Wang, Dr. Z. Huang, Dr. J. Montebello Department of

More information

Peak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam

Peak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam Peak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam University of Chicago CDH Proton Center LET study C. Reft 1, H. Ramirez 2 and M. Pankuch

More information

The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters

The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Interfractional Variations in the Setup of Pelvic Bony Anatomy and Soft Tissue, and Their Implications on the Delivery of Proton Therapy for Localized Prostate Cancer The Harvard community has made this

More information

HEAVY PARTICLE THERAPY

HEAVY PARTICLE THERAPY HEAVY PARTICLE THERAPY DR. G.V. GIRI KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY ICRO 2012 BHATINDA HEAVY PARTICLES USED IN A EFFORT TO IMPROVE TUMOR CONTROL, THAT DO NOT RESPOND TO PHOTONS OR ELECTRONS BETTER

More information

Development and Implementation of an Anthropomorphic Head & Neck Phantom for the Assessment of Proton Therapy Treatment Procedures

Development and Implementation of an Anthropomorphic Head & Neck Phantom for the Assessment of Proton Therapy Treatment Procedures Texas Medical Center Library DigitalCommons@TMC UT GSBS Dissertations and Theses (Open Access) Graduate School of Biomedical Sciences 8-2016 Development and Implementation of an Anthropomorphic Head &

More information

Active Scanning Beam 3 Checking Delivery/Dosimetry

Active Scanning Beam 3 Checking Delivery/Dosimetry Active Scanning Beam 3 Checking Delivery/Dosimetry C Algranati, J Salk, A Coray, A Lomax, E Pedroni, T Boeringer, S Lin, E Hug Center for Proton Radiation Therapy Checking Delivery/Dosimetry Contents Absolute

More information

The objective of this lecture is to integrate our knowledge of the differences between 2D and 3D planning and apply the same to various clinical

The objective of this lecture is to integrate our knowledge of the differences between 2D and 3D planning and apply the same to various clinical The objective of this lecture is to integrate our knowledge of the differences between 2D and 3D planning and apply the same to various clinical sites. The final aim will be to be able to make out these

More information

Disclosures. Proton therapy advantages. Why are comparing therapies difficult? Proton Therapy for Low Risk Prostate Cancer

Disclosures. Proton therapy advantages. Why are comparing therapies difficult? Proton Therapy for Low Risk Prostate Cancer Proton Therapy for Low Risk Prostate Cancer Disclosures No relevant financial disclosures This presentation will not discuss off-label or investigational treatments Andrew K. Lee, MD, MPH Associate Professor

More information

Andrew K. Lee, MD, MPH Associate Professor Department tof fradiation Oncology M.D. Anderson Cancer Center

Andrew K. Lee, MD, MPH Associate Professor Department tof fradiation Oncology M.D. Anderson Cancer Center Proton Therapy for Prostate Cancer Andrew K. Lee, MD, MPH Associate Professor Department tof fradiation Oncology M.D. Anderson Cancer Center Seungtaek Choi, MD Assistant Professor Department tof fradiation

More information

This content has been downloaded from IOPscience. Please scroll down to see the full text.

This content has been downloaded from IOPscience. Please scroll down to see the full text. This content has been downloaded from IOPscience. Please scroll down to see the full text. Download details: IP Address: 148.251.232.83 This content was downloaded on 25/11/2018 at 15:28 Please note that

More information

Protons Monte Carlo water-equivalence study of two PRESAGE formulations for proton beam dosimetry J. Phys.: Conf. Ser.

Protons Monte Carlo water-equivalence study of two PRESAGE formulations for proton beam dosimetry J. Phys.: Conf. Ser. Protons Monte Carlo water-equivalence study of two PRESAGE formulations for proton beam dosimetry T Gorjiara, Z Kuncic, J Adamovics and C Baldock 2013 J. Phys.: Conf. Ser. 444 012090 PRESAGE is a radiochromic

More information

Defining Target Volumes and Organs at Risk: a common language

Defining Target Volumes and Organs at Risk: a common language Defining Target Volumes and Organs at Risk: a common language Eduardo Rosenblatt Section Head Applied Radiation Biology and Radiotherapy (ARBR) Section Division of Human Health IAEA Objective: To introduce

More information

Application of Implanted Markers in Proton Therapy. Course Outline. McLaren Proton Therapy Center Karmanos Cancer Institute McLaren - Flint

Application of Implanted Markers in Proton Therapy. Course Outline. McLaren Proton Therapy Center Karmanos Cancer Institute McLaren - Flint Application of Implanted Markers in Proton Therapy Sung Yong Park, Ph.D. McLaren Proton Therapy Center Karmanos Cancer Institute McLaren - Flint AAPM 2016, SAM Therapy Educational Course, 2016.08.04. Course

More information

Independent Dose Verification for IMRT Using Monte Carlo. C-M M Charlie Ma, Ph.D. Department of Radiation Oncology FCCC, Philadelphia, PA 19111, USA

Independent Dose Verification for IMRT Using Monte Carlo. C-M M Charlie Ma, Ph.D. Department of Radiation Oncology FCCC, Philadelphia, PA 19111, USA Independent Dose Verification for IMRT Using Monte Carlo C-M M Charlie Ma, Ph.D. Department of Radiation Oncology FCCC, Philadelphia, PA 19111, USA Outline Why Monte Carlo for IMRT QA? Experimental verification

More information

Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana

Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana University of Groningen Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's

More information

Non-target dose from radiotherapy: Magnitude, Evaluation, and Impact. Stephen F. Kry, Ph.D., D.ABR.

Non-target dose from radiotherapy: Magnitude, Evaluation, and Impact. Stephen F. Kry, Ph.D., D.ABR. Non-target dose from radiotherapy: Magnitude, Evaluation, and Impact Stephen F. Kry, Ph.D., D.ABR. Goals Compare out-of-field doses from various techniques Methods to reduce out-of-field doses Impact of

More information

A Dosimetric Comparison of Whole-Lung Treatment Techniques. in the Pediatric Population

A Dosimetric Comparison of Whole-Lung Treatment Techniques. in the Pediatric Population A Dosimetric Comparison of Whole-Lung Treatment Techniques in the Pediatric Population Corresponding Author: Christina L. Bosarge, B.S., R.T. (R) (T) Indiana University School of Medicine Department of

More information

First, how does radiation work?

First, how does radiation work? Hello, I am Prajnan Das, Faculty Member in the Department of Radiation Oncology at The University of Texas MD Anderson Cancer Center. We are going to talk today about some of the basic principles regarding

More information

Clinical Aspects of Proton Therapy in Lung Cancer. Joe Y. Chang, MD, PhD Associate Professor

Clinical Aspects of Proton Therapy in Lung Cancer. Joe Y. Chang, MD, PhD Associate Professor Clinical Aspects of Proton Therapy in Lung Cancer Joe Y. Chang, MD, PhD Associate Professor Clinical Service Chief Thoracic Radiation Oncology Lung Cancer Basic Factors No. 1 cancer killer 161,840 patients

More information

Future upcoming technologies and what audit needs to address

Future upcoming technologies and what audit needs to address Future upcoming technologies and what audit needs to address Dr R.I MacKay History of audit Absolute dose - Simple phantom standard dose measurement Point doses in beams - Phantoms of relatively simple

More information

IMRT - the physician s eye-view. Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia

IMRT - the physician s eye-view. Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia IMRT - the physician s eye-view Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia The goals of cancer therapy Local control Survival Functional status Quality of life Causes

More information

A VMAT PLANNING SOLUTION FOR NECK CANCER PATIENTS USING THE PINNACLE 3 PLANNING SYSTEM *

A VMAT PLANNING SOLUTION FOR NECK CANCER PATIENTS USING THE PINNACLE 3 PLANNING SYSTEM * Romanian Reports in Physics, Vol. 66, No. 2, P. 401 410, 2014 A VMAT PLANNING SOLUTION FOR NECK CANCER PATIENTS USING THE PINNACLE 3 PLANNING SYSTEM * M. D. SUDITU 1,2, D. ADAM 1,2, R. POPA 1,2, V. CIOCALTEI

More information

Jeong-Eun Rah 1, Gwe-Ya Kim 2, Do Hoon Oh 1, Tae Hyun Kim 3, Jong Won Kim 4, Dae Yong Kim 3, Sung Yong Park 5 and Dongho Shin 3*

Jeong-Eun Rah 1, Gwe-Ya Kim 2, Do Hoon Oh 1, Tae Hyun Kim 3, Jong Won Kim 4, Dae Yong Kim 3, Sung Yong Park 5 and Dongho Shin 3* Rah et al. Radiation Oncology (2016) 11:140 DOI 10.1186/s13014-016-0717-4 RESEARCH Open Access A treatment planning study of proton arc therapy for para-aortic lymph node tumors: dosimetric evaluation

More information

Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana

Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana University of Groningen Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's

More information

Treatment Planning Evaluation of Volumetric Modulated Arc Therapy (VMAT) for Craniospinal Irradiation (CSI)

Treatment Planning Evaluation of Volumetric Modulated Arc Therapy (VMAT) for Craniospinal Irradiation (CSI) Treatment Planning Evaluation of Volumetric Modulated Arc Therapy (VMAT) for Craniospinal Irradiation (CSI) Tagreed AL-ALAWI Medical Physicist King Abdullah Medical City- Jeddah Aim 1. Simplify and standardize

More information

Effectiveness and Safety of Spot Scanning Proton Radiation Therapy for Skull Base Tumors: First Long Term Report of the PSI Experience

Effectiveness and Safety of Spot Scanning Proton Radiation Therapy for Skull Base Tumors: First Long Term Report of the PSI Experience Effectiveness and Safety of Spot Scanning Proton Radiation Therapy for Skull Base Tumors: First Long Term Report of the PSI Experience Carmen Ares, Antony J Lomax, Eugen B Hug, Alessandra Bolsi, Beate

More information

Proton Therapy: Where Are We Now and Where Are We Going? Erin Davis MSN, CRNP, ACNP BC Lead Nurse Practitioner

Proton Therapy: Where Are We Now and Where Are We Going? Erin Davis MSN, CRNP, ACNP BC Lead Nurse Practitioner Proton Therapy: Where Are We Now and Where Are We Going? Erin Davis MSN, CRNP, ACNP BC Lead Nurse Practitioner Genevieve Hollis MSN, CRNP, ANP-BC, AOCN Oncology Nurse Practitioner Advanced Senior Lecturer-B

More information

La ricerca e la terapia in adroterapia-2. R.Orecchia / P. Fossati

La ricerca e la terapia in adroterapia-2. R.Orecchia / P. Fossati La ricerca e la terapia in adroterapia-2 R.Orecchia / P. Fossati Dose (Gy) = energy (joule) / mass (kg) One degree of fever (from 37.5 to 38.5 ) > 4000 Gy RT small dose big damage Photons : Dose Resposne

More information

Biological Optimization of Hadrontherapy. Uwe Oelfke

Biological Optimization of Hadrontherapy. Uwe Oelfke 4/2/2012 page 1 Biological Optimization of Hadrontherapy Uwe Oelfke DKFZ Heidelberg (E040) Im Neuenheimer Feld 280 69120 Heidelberg, Germany u.oelfke@dkfz.de 4/2/2012 page 2 Contents Introduction and General

More information

THE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS

THE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS THE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS ICTP SCHOOL ON MEDICAL PHYSICS FOR RADIATION THERAPY DOSIMETRY AND TREATMENT PLANNING FOR BASIC AND ADVANCED APPLICATIONS March

More information

Medical physics is beautiful

Medical physics is beautiful Translational research in particle therapy Marco Durante Medical physics is beautiful Pisa, 31.10.2014 Relative dose 1. 2 1. 0 Tumor Durante & Loeffler, Nature Rev Clin Oncol 2010 0. 8 Normal tissue 0.

More information

Robust Optimization accounting for Uncertainties

Robust Optimization accounting for Uncertainties Robust Optimization accounting for Uncertainties Thomas Bortfeld Massachusetts General Hospital, Boston tbortfeld@mgh.harvard.edu Supported by: RaySearch Philips Medical Systems Outline 1. Optimality and

More information

Follow this and additional works at: Part of the Medicine and Health Sciences Commons

Follow this and additional works at:   Part of the Medicine and Health Sciences Commons Texas Medical Center Library DigitalCommons@TMC UT GSBS Dissertations and Theses (Open Access) Graduate School of Biomedical Sciences 8-2014 Development and Implementation of an Anthropomorphic Pediatric

More information

Image Guided Proton Therapy and Treatment Adaptation

Image Guided Proton Therapy and Treatment Adaptation Image Guided Proton Therapy and Treatment Adaptation www.hollandptc.nl d.r.schaart@tudelft.nl Cancer in The Netherlands About 1 in 3 people get cancer in some stage of their life 86.800 new cancer patients

More information

IGRT Protocol Design and Informed Margins. Conflict of Interest. Outline 7/7/2017. DJ Vile, PhD. I have no conflict of interest to disclose

IGRT Protocol Design and Informed Margins. Conflict of Interest. Outline 7/7/2017. DJ Vile, PhD. I have no conflict of interest to disclose IGRT Protocol Design and Informed Margins DJ Vile, PhD Conflict of Interest I have no conflict of interest to disclose Outline Overview and definitions Quantification of motion Influences on margin selection

More information

Advanced Technology Consortium (ATC) Credentialing Procedures for 3D Conformal Therapy Protocols 3D CRT Benchmark*

Advanced Technology Consortium (ATC) Credentialing Procedures for 3D Conformal Therapy Protocols 3D CRT Benchmark* Advanced Technology Consortium (ATC) Credentialing Procedures for 3D Conformal Therapy Protocols 3D CRT Benchmark* Purpose: To evaluate an institution s 3D treatment planning process and the institution

More information

Radiation Treatment Techniques: Where to find rooms for improvement?

Radiation Treatment Techniques: Where to find rooms for improvement? Radiation Treatment Techniques: Where to find rooms for improvement? Cedric Yu, D.Sc. Carl M. Mansfield, M.D. Professor University of Maryland School of Medicine Founder and CEO, Xcision Medical Systems,

More information

Evaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer

Evaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer 1 Charles Poole April Case Study April 30, 2012 Evaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer Abstract: Introduction: This study

More information

A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas

A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas Reid F. Thompson University of Pennsylvania, Philadelphia, Pennsylvania 1914 Sonal U. Mayekar Thomas

More information

Clinical Concept and History of Protons. Relevance and Limitations of Conformality. Gudrun Goitein

Clinical Concept and History of Protons. Relevance and Limitations of Conformality. Gudrun Goitein Clinical Concept and History of Protons Relevance and Limitations of Conformality Gudrun Goitein PSI Winter School January 2010 Bad Zurzach and PSI, Villigen Switzerland P + Who came first: The Clinical

More information

Intensity Modulated RadioTherapy

Intensity Modulated RadioTherapy Intensity Modulated RadioTherapy A clinical application of a small accelerator University Medical Center Groningen A.A. van t Veld PhD I. Hoveijn PhD part 1 part2 CERN/KVI accelerator school, Zeegse, June

More information

Radiation Related Second Cancers. Stephen F. Kry, Ph.D., D.ABR.

Radiation Related Second Cancers. Stephen F. Kry, Ph.D., D.ABR. Radiation Related Second Cancers Stephen F. Kry, Ph.D., D.ABR. Objectives Radiation is a well known carcinogen Atomic bomb survivors Accidental exposure Occupational exposure Medically exposed Radiotherapy

More information

Proton and helium beams: the present and the future of light ion beam therapy

Proton and helium beams: the present and the future of light ion beam therapy Proton and helium beams: the present and the future of light ion beam therapy Dr. Andrea Mairani Group Leader Biophysics in Particle Therapy Heidelberg Ion Beam Therapy Center HIT Department of Radiation

More information

PEDIATRIC ORBITAL TUMORS RADIOTHERAPY PLANNING

PEDIATRIC ORBITAL TUMORS RADIOTHERAPY PLANNING PEDIATRIC ORBITAL TUMORS RADIOTHERAPY PLANNING ANATOMY ANATOMY CONT ANATOMY CONT. ANATOMY CONT. EYE OF A CHILD Normal tissue tolerance doses (in conventional #) TD 5/5 TD 50/5 Endpoint Gy Gy Optic nerve

More information

RADIATION ONCOLOGY RESIDENCY PROGRAM Competency Evaluation of Resident

RADIATION ONCOLOGY RESIDENCY PROGRAM Competency Evaluation of Resident Resident s Name: RADIATION ONCOLOGY RESIDENCY PROGRAM Competency Evaluation of Resident Rotation: PHYS 703: Clinical Rotation 2 Inclusive dates of rotation: Feb. 26, 2016 Aug. 25, 2016 Director or Associate

More information

Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?

Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer? Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer? Dimos Baltas Dept. of Medical Physics & Engineering, Strahlenklinik, Klinikum Offenbach GmbH 63069 Offenbach, Germany

More information

Overview. Proton Therapy in lung cancer 8/3/2016 IMPLEMENTATION OF PBS PROTON THERAPY TREATMENT FOR FREE BREATHING LUNG CANCER PATIENTS

Overview. Proton Therapy in lung cancer 8/3/2016 IMPLEMENTATION OF PBS PROTON THERAPY TREATMENT FOR FREE BREATHING LUNG CANCER PATIENTS IMPLEMENTATION OF PBS PROTON THERAPY TREATMENT FOR FREE BREATHING LUNG CANCER PATIENTS Heng Li, PhD Assistant Professor, Department of Radiation Physics, UT MD Anderson Cancer Center, Houston, TX, 773

More information

Proton-Radiotherapy for Tumors of the Skull Base: Indications, Advantages, Limitations

Proton-Radiotherapy for Tumors of the Skull Base: Indications, Advantages, Limitations Proton-Radiotherapy for Tumors of the Skull Base: Indications, Advantages, Limitations Eugen B. Hug, MD Director, Center for Proton-Radiotherapy, Paul Scherrer Institut, Villigen and Chair of Proton-Radiotherapy.

More information

Real-time Volumetric Scintillation Dosimetry for Radiation Therapy

Real-time Volumetric Scintillation Dosimetry for Radiation Therapy Real-time Volumetric Scintillation Dosimetry for Radiation Therapy Sam Beddar, Ph.D., FCCPM, FAAPM Professor & Chief of Research Department of Radiation Physics The University of Texas MD Anderson Cancer

More information

Assessing Heterogeneity Correction Algorithms Using the Radiological Physics Center Anthropomorphic Thorax Phantom

Assessing Heterogeneity Correction Algorithms Using the Radiological Physics Center Anthropomorphic Thorax Phantom Assessing Heterogeneity Correction Algorithms Using the Radiological Physics Center Anthropomorphic Thorax Phantom David Followill, Ph.D. Associate Director Radiological Physics Center RPC History Lesson

More information

PTCOG 46. Educational Workshop Session IV. Head & Neck CLINICAL. J. Mizoe (NIRS, Japan)

PTCOG 46. Educational Workshop Session IV. Head & Neck CLINICAL. J. Mizoe (NIRS, Japan) PTCOG 46 Educational Workshop Session IV CLINICAL Head & Neck J. Mizoe (NIRS, Japan) Photon X-Ray γ-ray Fast Neutron Non-Charged Radiation Electron Proton Helium Light Ion Heavy Particle Carbon Neon Argon

More information

...some UK and Australian hadron therapy initiatives...

...some UK and Australian hadron therapy initiatives... Particles for patients, Radiotherapy with protons (and other ions): potential, problems and $$$s...some UK and Australian hadron therapy initiatives... David Thwaites Institute of Medical Physics Context

More information

*Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏

*Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏 林口 Proton Therapy in Ti Taiwan *Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏 Chang Gung Memorial Hospital at Lin-Kou, Taiwan 林口長庚紀念醫院 OCPA2010 at Beijing, China Aug. 5, 2010 Outline 1. The principle of proton radiotherapy

More information

Leila E. A. Nichol Royal Surrey County Hospital

Leila E. A. Nichol Royal Surrey County Hospital 2 nd UK and Ireland Dosimetry Check User Meeting Symposium Clatterbridge Cancer Centre, 24 th October 2012 Leila E. A. Nichol Royal Surrey County Hospital Leila.Nichol@nhs.net *My experience with Dosimetry

More information

Reena Phurailatpam. Intensity Modulated Radiation Therapy of Medulloblastoma using Helical TomoTherapy: Initial Experience from planning to delivery

Reena Phurailatpam. Intensity Modulated Radiation Therapy of Medulloblastoma using Helical TomoTherapy: Initial Experience from planning to delivery Intensity Modulated Radiation Therapy of Medulloblastoma using Helical TomoTherapy: Initial Experience from planning to delivery Reena Phurailatpam Tejpal Gupta, Rakesh Jalali, Zubin Master, Bhooshan Zade,

More information

Estimated risk of radiation-induced lung cancer in paediatric patients following electron, photon and proton therapy

Estimated risk of radiation-induced lung cancer in paediatric patients following electron, photon and proton therapy U N I V E R S I T Y O F B E R G E N Estimated risk of radiation-induced lung cancer in paediatric patients following electron, photon and proton therapy Camilla H Stokkevåg 1, Grete-May Engeseth 1, Kristian

More information

Modern Pencil Beam Scanning (PBS) Where We Are and Where We Are Going

Modern Pencil Beam Scanning (PBS) Where We Are and Where We Are Going Modern Pencil Beam Scanning (PBS) Where We Are and Where We Are Going Disclaimers No disclosures of any kind. The views in this presentation are my own and not necessarily endorsed by my employer or colleagues.

More information

REVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria

REVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria REVISITING ICRU VOLUME DEFINITIONS Eduardo Rosenblatt Vienna, Austria Objective: To introduce target volumes and organ at risk concepts as defined by ICRU. 3D-CRT is the standard There was a need for a

More information

Transition to Heterogeneity Corrections. Why have accurate dose algorithms?

Transition to Heterogeneity Corrections. Why have accurate dose algorithms? Transition to Heterogeneity Corrections Eric E. Klein, M.S., Washington University, St. Louis, MO Craig Stevens, M.D., Ph.D., MD Anderson Cancer Center, Houston, TX Nikos Papinikolou, Ph.D., University

More information

Outline. Outline 3/30/12. Second Cancers from. Radiotherapy Procedures. Stephen F. Kry, Ph.D., D.ABR.

Outline. Outline 3/30/12. Second Cancers from. Radiotherapy Procedures. Stephen F. Kry, Ph.D., D.ABR. Second Cancers from Radiotherapy Procedures Stephen F. Kry, Ph.D., D.ABR. Outline Radiation and cancer induction Medically exposed people Estimating risk of second cancers Minimizing the risk Outline Radiation

More information

Radiation qualities in carbon-ion radiotherapy at NIRS/HIMAC

Radiation qualities in carbon-ion radiotherapy at NIRS/HIMAC Radiation qualities in carbon-ion radiotherapy at NIRS/ Shunsuke YONAI Radiological Protection Section Research Center for Charged Particle Therapy National Institute of Radiological Sciences (NIRS) E-mail:

More information

Electron therapy Class 3: Clinical procedures

Electron therapy Class 3: Clinical procedures Electron therapy Class 3: Clinical procedures Laurence Court lecourt@mdanderson.org Reference: Faiz M. Khan, The Physics of Radiation Therapy Slide acknowledgements: Karl Prado, Rebecca Howell, Kent Gifford,

More information

Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana

Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana University of Groningen Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's

More information

Uncertainties in proton therapy: Analysis of the effects of density changes, calibration curve errors and setup errors in proton dose distributions.

Uncertainties in proton therapy: Analysis of the effects of density changes, calibration curve errors and setup errors in proton dose distributions. Uncertainties in proton therapy: Analysis of the effects of density changes, calibration curve errors and setup errors in proton dose distributions. A treatment planning study performed on water phantoms

More information

Learning Objectives. Clinically operating proton therapy facilities. Overview of Quality Assurance in Proton Therapy. Omar Zeidan

Learning Objectives. Clinically operating proton therapy facilities. Overview of Quality Assurance in Proton Therapy. Omar Zeidan Overview of Quality Assurance in Proton Therapy Omar Zeidan AAPM 2012 Charlotte, NC July 30 st, 2012 Learning Objectives Understand proton beam dosimetry characteristics and compare them to photon beams

More information

IMAT: intensity-modulated arc therapy

IMAT: intensity-modulated arc therapy : intensity-modulated arc therapy M. Iori S. Maria Nuova Hospital, Medical Physics Department Reggio Emilia, Italy 1 Topics of the talk Rotational IMRT techniques: modalities & dedicated inverse-planning

More information

Head and Neck Treatment Planning: A Comparative Review of Static Field IMRT RapidArc TomoTherapy HD. Barbara Agrimson, BS RT(T)(R), CMD

Head and Neck Treatment Planning: A Comparative Review of Static Field IMRT RapidArc TomoTherapy HD. Barbara Agrimson, BS RT(T)(R), CMD Head and Neck Treatment Planning: A Comparative Review of Static Field IMRT RapidArc TomoTherapy HD Barbara Agrimson, BS RT(T)(R), CMD Disclaimer This presentation will mention equipment by trade name.

More information

Additional Questions for Review 2D & 3D

Additional Questions for Review 2D & 3D Additional Questions for Review 2D & 3D 1. For a 4-field box technique, which of the following will deliver the lowest dose to the femoral heads? a. 100 SSD, equal dmax dose to all fields b. 100 SSD, equal

More information

Intensity modulation in radiotherapy: photons versus protons in the paranasal sinus

Intensity modulation in radiotherapy: photons versus protons in the paranasal sinus Radiotherapy and Oncology 66 (2003) 11 18 www.elsevier.com/locate/radonline Intensity modulation in radiotherapy: photons versus protons in the paranasal sinus Anthony John Lomax a, *, Michael Goitein

More information

Stereotactic Body Radiotherapy for Lung Lesions using the CyberKnife of-the-art and New Innovations

Stereotactic Body Radiotherapy for Lung Lesions using the CyberKnife of-the-art and New Innovations Stereotactic Body Radiotherapy for Lung Lesions using the CyberKnife State-of of-the-art and New Innovations Chad Lee, PhD CK Solutions, Inc. and CyberKnife Centers of San Diego Outline Basic overview

More information

Stereotaxy. Outlines. Establishing SBRT Program: Physics & Dosimetry. SBRT - Simulation. Body Localizer. Sim. Sim. Sim. Stereotaxy?

Stereotaxy. Outlines. Establishing SBRT Program: Physics & Dosimetry. SBRT - Simulation. Body Localizer. Sim. Sim. Sim. Stereotaxy? Establishing SBRT Program: Physics & Dosimetry Lu Wang, Ph.D. Radiation Oncology Department Fox Chase Cancer Center Outlines Illustrate the difference between SBRT vs. CRT Introduce the major procedures

More information

Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?

Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer? Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer? Dimos Baltas 1,3, Natasa Milickovic 1, Nikolaos Zamboglou 2 1 Dept. of Medical Physics & Engineering, 2 Strahlenklinik,

More information

Linac or Non-Linac Demystifying And Decoding The Physics Of SBRT/SABR

Linac or Non-Linac Demystifying And Decoding The Physics Of SBRT/SABR Linac or Non-Linac Demystifying And Decoding The Physics Of SBRT/SABR PhD, FAAPM, FACR, FASTRO Department of Radiation Oncology Indiana University School of Medicine Indianapolis, IN, USA Indra J. Das,

More information